SPPI (NASDAQ) up above 7 usd in a bull trend with strong underlying fundamental catalysts

BFRM (NASDAQ) up 9% to 2,9 usd

ONXX (NASDAQ) up 7% from oversold conditions

We sold JAV (AMEX) with 55% gain and AEZS (NASDAQ) with  20% gain before their results next week

TICKER            BUY AREA     QUOTE NOW      POSITION           DRIVER

THRX (NASDAQ) 15                14,8           SHORT TERM   FDA PDUFA Telavancin on 9/16/09
VVUS (NASDAQ)USD 6,9 USD      7                LT         STRONG CONSENSUS, PENDING DATA
HGSI (NASDAQ) USD 14,42       15                LT      LUPUS DRUG SUCCESSFUL
ARNA (NASDAQ) USD 5,05       4,8       SHORT TERM PENDING SEPTEMBER CLINICAL DATA
SQNM (NASDAQ) USD 5,85    6,35(+8%) SOLD
TSPT (NASDAQ) USD 7,8          8,1        LT INTERMEZZO PENDING FDA APPROVAL-PARTNERSHIP
ALXA (NASDAQ) USD 2,28         2,45            LT                 STRONG CONSENSUS
CYTK (NASDAQ) USD 3             3            LT      STRONG CONSENSUS PENDING CLINICAL DATA
ARIA (NASDAQ) USD 2,35    1,90 SOLD (-19%)
AEZS(NASDAQ) USD 2,1        2,53 (+20%)            LT   STRONG CONSENSUS, PENDING DATA
JAV (AMEX)   USD 1,3          1,98 SOLD(+55%)
NPSP (NASDAQ) USD 4,7     4,3               LT              STRONG CONSENSUS
ONXX(NASDAQ) USD 35,9   32,3                LT                     OVERSOLD
IDIX (NASDAQ) USD 4,44        4,2 SOLD(-5%)
SNTS (NASDAQ) USD 2,81    3,25 SOLD(+17%)
BFRM (NASDAQ) USD 2,85   2,9        LONG TERM
OCLS (NASDAQ) USD 2,85    2,45 SOLD (-15%)
TRGT (NASDAQ) USD 5,5     8,7 SOLD(+60%)
OREX (NASDAQ) USD 5,35    6,45 SOLD(+20%)
FOLD (NASADQ) USD 10    10,4       LONG TERM       PLICERA, AMIGAL, STRONG CONSENSUS
SOMX (NASDAQ) USD 1,10  1,38 SOLD (+25%)
DDSS (NASDAQ) USD 2,65    1,9      HOLD                            TRAZODONE 
XNPT (NASDAQ) USD 21,85  20,7   LONG TERM            XP19986 POSITIVE TRIAL 6/30/09
VNDA (NASDAQ) USD12,1    15,2 SOLD (+25%)
CYTR (NASDAQ) USD 1,02    1     LONG TERM                 STRONG CONSENSUS
JAZZ (NASDAQ) USD 4,95   7,3 SOLD (+45%)
PARD (NASDAQ) USD 5    5,9 PROFIT TAKING(+18%)
PARD (NASDAQ) USD 6,6  rebought 7/2 7,2 SOLD (+9%)
INCY (NASDAQ) USD 3,5      5,2    SOLD (+50%)
ISTA (NASDAQ) USD 4,1   5,1         LONG TERM               BEPREVE FDA PDUFA 9/12/09
SLXP (NASDAQ) USD 9,9   12,55 SOLD(+25%)
MAPP (NASDAQ) USD 11,3  9,8    REBUYING LONG TERM        STRONG CONSENSUS
ARYX (NASDAQ) USD 4,5    SOLD 2,5 (-45%)
ARRY (NASDAQ) USD 3,1    4,2 SOLD (+30%)
GTXI (NASDAQ) USD 9,5  9,5         LONG TERM FDA                   PDUFA 10/30/09
UTHR (NASDAQ) USD 84    96 SOLD (+15%)
NGSX (NASDAQ) USD 6,4    8,2 SOLD(+30%)
VICL (NASDAQ) USD 3      3,5         LONG TERM                            SWINE FLU
STAA (NASDAQ) USD 3,3 2,75         LONG TERM               FDA CLEARENCE FOR Epiphany(TM)
ALTH (NASDAQ) 7,9      7,6            LONG TERM                    FDA PDUFA 9/24/09
AMAG (NASDAQ) 52,8   45,1             LONG TERM           FDA APPROVES FERAHEME 6/30/09
XOMA (NASDAQ) 1,2    0,8           LONG TERM                            OVERSOLD
HEB (AMEX) 3,3(5%OF CAPITAL) 2,25 SOLD(-35%)
HEB (AMEX) was rebought after 100% gain (see old posts)
MRNA (NASDAQ) 3,3           1,4 SOLD (-55%)
RIGL (NASDAQ) USD 10        10,1 SOLD FLAT
MITI (NASDAQ) USD 6    6,1              LONG TERM                  STRONG CONSENSUS            
MNKD (NASDAQ) USD 8,3     7,95 SOLD(-4%)
SVNT (NASDAQ) USD 7,10     13 SOLD(+90%)
NPSP (NASDAQ) 3,1 USD      4,75 SOLD(+50%)
SCLN (NASDAQ) 2,25 USD      2,7 SOLD (+20%) 
MAPP (NASDAQ) 8 USD (posts from 5/26) PROFIT TAKED(+45%) LEVADEX
VNDA (NASDAQ) 8 USD (see old post 5/8) PROFIT TAKED(+80%) FANAT
CLDA (NASDAQ) 15,7 USD 14,5           LONG TERM
CTIC (NASDAQ) 2,10 USD    1,39 SOLD (-35%)
ANPI (NASDAQ) 2 USD         1,39 SOLD(-30%)
MEDX (NASDAQ) 7,5 USD     8,7 PROFIT TAKING(+20%)
MNTA (NASDAQ) 8,9 USD  10,1             LONG TERM                   STRONG CONSENSUS
ACAD (NASDAQ) 2,6 USD      5 SOLD (+95%)
ACOR (NASDAQ) 24 USD        23,5 SOLD (-2%) FAMPRIDINE-SR, FDA PDUFA 10/22/09
BDSI (NASDAQ) USD 5,45    PROFIT TAKED 6,3 (+18%)
BDSI (NASDAQ) 6,6  rebought at 5,1      SHORT TERM         ONSOLIS APPROVED BY FDA
DNDN (NASDAQ) 22 USD (see old post 4/27) 23,9 LONG TERM             PROVENGE
SPPI (NASDAQ) 4 USD    (see ols post 5/12) 6/12 PROFIT TAKING (+35%)
SPPI (NASDAQ) 5,85 USD          7,4 PROFIT TAKING(+28%)
SPPI (NASDAQ) 6,5 USD rebought 7/2 7,1 LT ZEVALIN FDA PDUFA 09/07/09 FUSILEV PDUFA 08/10/09